
    
      This is a 5-year observational study. Sixteen-hundred and fifty (1650) subjects, between the
      ages of 50 and 90,years old, with Subjective Cognitive Impairment, Mild Cognitive Impairment,
      Mild Cognitive Impairment with subcortical vascular lesions, Alzheimer's Disease, Mixed
      dementia, Lewy Body Dementia, Parkinson's Disease Dementia, Parkinson's Disease with Mild
      Cognitive Impairment and Frontotemporal Dementia, as well as 650 healthy elderly subjects
      without cognitive complaints or deficits, will be enrolled into this study from up to 30
      centres across Canada. All subjects involved in the study will undergo rigorous evaluations
      at baseline, including clinical assessment, neuropsychological assessment, genomics and
      neuroimaging. Biological samples from blood, saliva, urine, fecal matter, buccal cells and
      cerebrospinal fluid will be collected, stored, and analyzed. Basic follow-up determining if
      there has been any change in their diagnosis will be carried out annually and longitudinal
      re-evaluation will be carried out after two years.
    
  